Hospital
Kettering Medical Center
Kettering Medical Center was paid $10.83M by Medicaid between Jun 2019 and Dec 2024, across 163 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoKETTERING MEDICAL CENTER
TROY, OH 45373
TROY, OH 45373
33aNPI1023587045assigned 11/20/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.83M
24GClaims238,031
24DCodes billed163
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#74 of 101
Median peer was paid$22.32M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KO, TIMOTHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 6,447 | $280K | |
| 2020 | 13,394 | $567K | |
| 2021 | 23,609 | $1.18M | |
| 2022 | 26,375 | $1.34M | |
| 2023 | 115,078 | $5.12M | |
| 2024incomplete | 53,128 | $2.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 24,753 | 22,462 | $2.74M |
| 96361 | Intravenous infusion, hydration; each additional hour | 19% | 6,289 | 4,841 | $2.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 12,579 | 11,327 | $1.66M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.9% | 4,769 | 4,024 | $638K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 2,301 | 1,912 | $569K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.6% | 1,889 | 1,600 | $498K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.2% | 1,738 | 1,414 | $456K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 2,770 | 2,529 | $342K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.8% | 824 | 719 | $195K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 1,327 | 1,056 | $175K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.3% | 976 | 828 | $143K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.3% | 1,165 | 1,049 | $139K |
151 more codes
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.3% | 545 | $138K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 3,613 | $127K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 429 | $80K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 373 | $69K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 477 | $63K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 392 | $63K |
| G0378 | Hospital observation service, per hour | <1% | 840 | $62K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 5,623 | $61K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 558 | $46K |
| 76830 | Ultrasound, transvaginal | <1% | 453 | $35K |
| 72131 | <1% | 484 | $30K | |
| 93971 | <1% | 407 | $30K | |
| 93356 | <1% | 94 | $26K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 17,109 | $26K |
| 71250 | <1% | 358 | $26K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,903 | $22K |
| 62323 | <1% | 59 | $21K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 163 | $19K |
| 76642 | <1% | 157 | $18K | |
| 82805 | <1% | 559 | $18K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 621 | $15K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 96 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,381 | $13K |
| 12001 | <1% | 71 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,145 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,665 | $9K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 180 | $8K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 115 | $8K |
| 73030 | <1% | 565 | $7K | |
| 93970 | <1% | 52 | $7K | |
| 84484 | <1% | 6,704 | $6K | |
| 74018 | <1% | 189 | $6K | |
| 73562 | <1% | 382 | $5K | |
| 96367 | <1% | 136 | $5K | |
| 73630 | <1% | 717 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,785 | $5K |
| 72110 | <1% | 93 | $5K | |
| 90715 | <1% | 293 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 307 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 5,941 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,508 | $4K |
| 73130 | <1% | 478 | $4K | |
| 93017 | <1% | 45 | $4K | |
| 73610 | <1% | 597 | $4K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 20 | $4K |
| 80076 | <1% | 5,656 | $3K | |
| 73502 | <1% | 196 | $3K | |
| J3490 | Unclassified drugs | <1% | 1,290 | $3K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $3K |
| 76536 | <1% | 24 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,028 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,624 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,862 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,780 | $2K |
| 70486 | <1% | 94 | $2K | |
| 70496 | <1% | 13 | $2K | |
| 73110 | <1% | 329 | $2K | |
| 81001 | <1% | 7,951 | $2K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 94 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 28 | $2K |
| 73080 | <1% | 122 | $2K | |
| 72128 | <1% | 48 | $1K | |
| 73560 | <1% | 186 | $1K | |
| 97162 | <1% | 17 | $1K | |
| 96376 | <1% | 1,144 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 180 | $1K |
| 83690 | <1% | 5,578 | $1K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 77 | $973.69 |
| 83735 | <1% | 1,248 | $965.72 | |
| 72100 | <1% | 65 | $919.01 | |
| 77065 | Tomosynthesis, mammo | <1% | 30 | $890.70 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 508 | $882.84 |
| 87529 | <1% | 787 | $863.69 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 508 | $764.50 |
| 81025 | <1% | 4,032 | $752.11 | |
| 29125 | <1% | 294 | $640.81 | |
| 86900 | <1% | 26 | $639.37 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 484 | $605.88 |
| 87634 | <1% | 321 | $563.87 | |
| 81003 | <1% | 1,985 | $544.12 | |
| 71101 | <1% | 33 | $535.03 | |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $457.48 |
| 85027 | <1% | 650 | $437.28 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 812 | $429.58 |
| 85378 | <1% | 1,264 | $407.22 | |
| 83605 | <1% | 1,145 | $398.93 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 797 | $390.74 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 86 | $384.31 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,400 | $369.03 |
| 73590 | <1% | 30 | $360.89 | |
| 87040 | <1% | 941 | $355.86 | |
| 84702 | <1% | 241 | $350.28 | |
| 83880 | <1% | 543 | $311.33 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 741 | $278.75 |
| 80320 | <1% | 101 | $257.09 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 86 | $249.73 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,858 | $203.09 |
| 87210 | <1% | 219 | $185.41 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 343 | $180.38 |
| 87077 | <1% | 440 | $170.07 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 429 | $161.19 |
| 86141 | <1% | 72 | $154.24 | |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 27 | $147.41 |
| 84145 | <1% | 418 | $138.61 | |
| 85610 | <1% | 753 | $132.67 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 267 | $127.53 |
| 73090 | <1% | 20 | $107.80 | |
| 73140 | <1% | 30 | $102.90 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 106 | $101.05 |
| 85651 | <1% | 263 | $90.82 | |
| 87186 | <1% | 365 | $90.74 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,814 | $88.44 |
| 85007 | <1% | 337 | $83.21 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 663 | $81.71 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 400 | $77.53 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,998 | $68.77 |
| 82550 | <1% | 241 | $62.77 | |
| 86901 | <1% | 26 | $49.19 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,350 | $46.33 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 918 | $32.52 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 171 | $29.52 |
| 87070 | <1% | 71 | $25.65 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 243 | $24.85 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 700 | $24.21 |
| 85730 | <1% | 231 | $24.03 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 80 | $21.64 |
| 36415 | Collection of venous blood by venipuncture | <1% | 18 | $19.68 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 148 | $15.98 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 47 | $11.40 |
| 81015 | <1% | 108 | $9.36 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 715 | $9.20 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 535 | $7.21 |
| J2704 | Injection, propofol, 10 mg | <1% | 323 | $4.95 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 339 | $2.33 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 19 | $1.47 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 18 | $1.17 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 19 | $1.05 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 603 | $0.31 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 17 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 26 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 162 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 32 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 28 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 19 | $0.00 |
| 84703 | 0% | 17 | $0.00 | |
| 70498 | 0% | 13 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 14 | $0.00 |
| 82010 | 0% | 157 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 71 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 131 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKO, TIMOTHY (KETTERING HEALTH CFO)
| Provider | Location | Paid |
|---|---|---|
| Dayton Osteopathic Hospital | Dayton, OH | $111.27M |
| Alliance Physicians INC | Kettering, OH | $38.76M |
| Kettering Medical Center | Kettering, OH | $37.96M |
| Beavercreek Medical Center | Beavercreek, OH | $30.49M |
| The Fort Hamilton Hospital | Hamilton, OH | $27.06M |
| Kettering Medical Center | Miamisburg, OH | $20.00M |
| Greene Memorial Hospital INC | Xenia, OH | $11.31M |
| Kettering Independent Medical Group INC | Miamisburg, OH | $8.39M |
| Kettering Affiliated Health Services | Miamisburg, OH | $2.12M |
| Greene Memorial Hospital, INC. | Jamestown, OH | $1.53M |
| Alliance Physicians INC | Moraine, OH | $1.42M |
| Alliance Physicians INC | Huber Heights, OH | $1.06M |
| Greene Memorial Hospital INC | Yellow Springs, OH | $843K |
| Alliance Physicians INC | Miamisburg, OH | $744K |
| Greene Memorial Hospital INC | Cedarville, OH | $703K |
| Alliance Physicians INC | Xenia, OH | $645K |
| Alliance Physicians INC | Springboro, OH | $616K |
| Alliance Physicians INC | Kettering, OH | $599K |
| Sycamore Primary Care Group | Miamisburg, OH | $564K |
| Alliance Physicians INC | Beavercreek, OH | $486K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.